EXPRESSION OF LEUKEMIA INHIBITORY FACTOR IN HUMAN ENDOMETRIUM AND PLACENTA

Citation
K. Kojima et al., EXPRESSION OF LEUKEMIA INHIBITORY FACTOR IN HUMAN ENDOMETRIUM AND PLACENTA, Biology of reproduction, 50(4), 1994, pp. 882-887
Citations number
31
Categorie Soggetti
Reproductive Biology
Journal title
ISSN journal
00063363
Volume
50
Issue
4
Year of publication
1994
Pages
882 - 887
Database
ISI
SICI code
0006-3363(1994)50:4<882:EOLIFI>2.0.ZU;2-F
Abstract
Leukemia inhibitory factor (LIF), a cytokine that induces macrophage d ifferentiation in the murine M1 myeloid leukemia cell line, is essenti al for blastocyst implantation in mice. However, its expression and th e role it plays in the human uterus are unknown. To clarify these issu es, we examined LIF gene expression in the human uterus by Northern bl ot hybridization and by a quantitative reverse transcription-polymeras e chain reaction (RT-PCR) method. Analysis of LIF mRNA showed two hybr idization bands, with estimated mRNA sizes of about 4.0-kb pairs and 1 .8-kb pairs. LIF mRNA was detected at high levels in endometrial tissu e and decidua, but at low levels in the chorionic villus in first trim ester and term placenta. In the secretory phase, the endometrial tissu e showed higher LIF expression than in the proliferative phase (9.5-fo ld; p < 0.01). The endometrial tissues were separated into a stroma-en riched fraction (SF) and an epithelium-enriched fraction (EF), and the LIF mRNA levels in each fraction were examined by quantitative RT-PCR . These levels were higher in the EF than in the SF (3.3-fold; p < 0.0 5). These findings suggest that, in humans. LIF plays a role in uterin e function during the menstrual cycle, as well as during pregnancy.